Advertisement

Interventional Radiology: Partial Splenic Embolization

  • Nobuhiko TaniaiEmail author
  • Hiroshi Yoshida
  • Eiigi Uchida
Chapter

Abstract

Partial splenic embolization (PSE) is an effective treatment for complications associated with hypersplenism and portal hypertension, such as esophagogastric varices, pancytopenia, portal hypertensive gastropathy, and ascites. PSE is indicated for all complications associated with hypersplenism and portal hypertension. PSE should not be indicated for patients with Child’s C cirrhosis. A femoral artery approach is used for selective catheterization of the splenic artery. After an injection of antibiotics and steroids, embolization is achieved by injecting gelatin sponge cubes or coils. The most common complications after PSE are fever and left-sided abdominal pain, followed by retention of pleural effusion and ascites, splenic abscess, gastric ulcer, and others. There were no appreciable changes in the incidences of complications, but no patient had serious complications such as splenic abscess or portal vein thrombosis, which can frequently occur after splenectomy. PSE is a straightforward surgical technique associated with minimal complications and effectively improves hypersplenism and various complications associated with portal hypertension.

Keywords

Partial splenic embolization (PSE) Portal hypertension Hypersplenism Esophagogastric varices Pancytopenia 

References

  1. 1.
    Tajiri T, Onda M, Yoshida H, et al. Long-term hematological effects of partial splenic embolization in hepatic cirrhosis. Hepatogastroenterology. 2002;49:1445–8.PubMedGoogle Scholar
  2. 2.
    Taniai N, Onda M, Tajiri T, et al. Endoscopic variceal ligation (EVL) combined with partial splenic embolization (PSE). Hepatogastroenterology. 1999;46:2849–53.PubMedGoogle Scholar
  3. 3.
    Yoshida H, Mamada Y, Taniai N, et al. Long-term results of partial splenic artery embolization as supplemental treatment for hepatic encephalopathy associated with portal-systemic shunts. Am J Gastroenterol. 2005;100:43–7.CrossRefGoogle Scholar
  4. 4.
    Maddison FE. Embolic therapy for hypersplenism. Intervest Radiol. 1973;8:280–1.CrossRefGoogle Scholar
  5. 5.
    Spigos DG, Jonasson O, Mozes M, et al. Partial splenic embolization in the treatment of hypersplenism. AJR. 1979;132:777–82.CrossRefGoogle Scholar
  6. 6.
    Yoshida H, Mamada Y, Taniai N, et al. Partial partial splenic embolization. Hepatol Res. 2008;28:225–33.CrossRefGoogle Scholar
  7. 7.
    Ishikawa T, Abe S, Kojima Y, et al. Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve. Exp Ther Med. 2015;10:1334–8.CrossRefGoogle Scholar
  8. 8.
    Kondo C, Atsukawa M, Tsubota A, et al. Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C. Intern Med. 2015;54:119–26.CrossRefGoogle Scholar
  9. 9.
    Shimizu H, Takatsuka K, Nakano H, et al. Long-term evaluation of partial splenic embolization followed by interferon therapy in patient with hepatitis C virus (HCV) cirrhosis and thrombocytopenia. Inter Med. 2014;53:925–31.CrossRefGoogle Scholar
  10. 10.
    Ikeda N, Imanishi H, Aizawa N, et al. Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count. Hepatol Res. 2014;44:829–36.CrossRefGoogle Scholar
  11. 11.
    Barcena R, Moreno A, Foruny JR, et al. Partial splenic embolization and peg-INF plus RBV in liver transplanted patients with hepatitis C recurrence; safety, efficacy and long-term outcome. Clin Transpl. 2010;24:366–74.CrossRefGoogle Scholar
  12. 12.
    Miyake Y, Ando M, Kaji E, et al. Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Hepatol Res. 2008;38:980–6.CrossRefGoogle Scholar
  13. 13.
    Foruny FR, Blazquez J, Moreno A, et al. Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization. Eur J Gastroenterol Hepatol. 2005;17:157–64.CrossRefGoogle Scholar
  14. 14.
    Moreno A, Barcena R, Blazqez J, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhotic HIV/HCV patients prior to pegylated interferon and ribavirin. Antivir Ther. 2004;9:1027–30.PubMedGoogle Scholar
  15. 15.
    Huang JH, Gao F, Gu YK, et al. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. World J Gastroenterol. 2007;13:6593–7.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Ooka Y, Chiba T, Ogasawara S, et al. Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia. Biomed Res Int. 2014;2014:960628.CrossRefGoogle Scholar
  17. 17.
    Portielje JE, Westendorp RG, Kluin-Nelemans HC, et al. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549–54.CrossRefGoogle Scholar
  18. 18.
    Schwartz J, Leber MD, Gillis S, et al. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol. 2003;72:94–8.CrossRefGoogle Scholar
  19. 19.
    Neylon AJ, Saunders PW, Howard MR, et al. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol. 2003;122:966–74.CrossRefGoogle Scholar
  20. 20.
    Uchida Y, Minoshima S, Miyazaki M, et al. Normalized spleen/liver ratios on 111In-labelled platelet scintigraphy to predict the outcome of partial splenic embolization in patients with idiopathic thrombocytopenic purpura. Nucl Med Commun. 2000;21:441–7.CrossRefGoogle Scholar
  21. 21.
    Miyazaki M, Itoh H, Kaiho T, et al. Partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura. Am J Roentgenol. 1994;163:123–6.CrossRefGoogle Scholar
  22. 22.
    Kimura F, Itoh H, Ambiru S, et al. Long-term results of initial and repeated partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura. Am J Roentgenol. 2002;179:1323–6.CrossRefGoogle Scholar
  23. 23.
    Pratl B, Benesch M, Lackner H, et al. Partial splenic embolization in children with hereditary spherocytosis. Eur J Haematol. 2008;80:76–80.PubMedGoogle Scholar
  24. 24.
    Forsythe RM, Harbrecht BG, Peitzman AB. Blunt splenic trauma. Scand J Surg. 2006;95:146–51.CrossRefGoogle Scholar
  25. 25.
    Rajani RR, Claridge JA, Yowler CJ, et al. Improved outcome of adult blunt splenic injury: a cohort analysis. Surgery. 2006;140:625–31.CrossRefGoogle Scholar
  26. 26.
    Demetriades D, Hadjizacharia P, Constantinou C, et al. Selective nonoperative management of penetrating abdominal solid organ injuries. Ann Surg. 2006;244:620–8.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Smith HE, Biffl WL, Majercik SD, Jednacz J, Lambiase R, Cioffi WG. Splenic artery embolization: have we gone too far? J Trauma. 2006;61:541–4.CrossRefGoogle Scholar
  28. 28.
    Stein DM, Scalea TM. Nonoperative management of spleen and liver injuries. J Intensive Care Med. 2006;21:296–304.CrossRefGoogle Scholar
  29. 29.
    Gaarder C, Dormagen JB, Eken T, et al. Nonoperative management of splenic injuries: improved results with angioembolization. J Trauma. 2006;61:192–8.CrossRefGoogle Scholar
  30. 30.
    Bessoud B, Denys A, Calmes JM, et al. Nonoperative management of traumatic splenic injuries: is there a role for proximal splenic artery embolization? Am J Roentgenol. 2006;186:779–85.CrossRefGoogle Scholar
  31. 31.
    Cooney R, Ku J, Cherry R, et al. Limitations of splenic angioembolization in treating blunt splenic injury. J Trauma. 2005;59:926–32.CrossRefGoogle Scholar
  32. 32.
    Rhodes CA, Dinan D, Jafri SZ, et al. Clinical outcome of active extravasation in splenic trauma. Emerg Radiol. 2005;11:348–52.CrossRefGoogle Scholar
  33. 33.
    Ekeh AP, McCarthy MC, Woods RJ, et al. Complications arising from splenic embolization after blunt splenic trauma. Am J Surg. 2005;189:335–9.CrossRefGoogle Scholar
  34. 34.
    Haan JM, Bochicchio GV, Kramer N, et al. Non-operative management of blunt splenic injury: a 5-year experience. J Trauma. 2005;58:492–8.CrossRefGoogle Scholar
  35. 35.
    Hagiwara A, Fukushima H, Murata A, et al. Blunt splenic injury: usefulness of transcatheter arterial embolization in patients with a transient response to fluid resuscitation. Radiology. 2005;235:57–64.CrossRefGoogle Scholar
  36. 36.
    Wahl WL, Ahrns KS, Chen S, et al. Blunt splenic injury: operation versus angio-graphic embolization. Surgery. 2004;136:891–9.CrossRefGoogle Scholar
  37. 37.
    Firat A, Boyvat F, Moray G, et al. Comparison of two different percutaneous splenic artery interventions in the treatment of hypersplenism: preliminary report. Transplant Proc. 2005;37:1094–8.CrossRefGoogle Scholar
  38. 38.
    Ohmoto K, Yamamoto S. Prevention of variceal recurrence, bleeding, and death in cirrhosis patients with hypersplenism, especially those with severe thrombocytopenia. Hepatogastroenterology. 2003;50:1766–9.PubMedGoogle Scholar
  39. 39.
    Nio M, Hayashi Y, Sano N, et al. Long-term efficacy of partial splenic embolization in children. J Pediatr Surg. 2003;38:1760–2.CrossRefGoogle Scholar
  40. 40.
    Tajiri T, Onda M, Taniai N, et al. A comparison of combination endoscopic therapy and interventional radiology with esophageal transection for the treatment of esophageal varices. Hepatogastroenterology. 2002;49:1552–4.PubMedGoogle Scholar
  41. 41.
    Hidaka H, Kokubu S, Saigenji K, et al. Restoration of thrombopoietin production after partial splenic embolization leads to resolution of thrombocytopenia in liver cirrhosis. Hepatol Res. 2002;23:265–73.CrossRefGoogle Scholar
  42. 42.
    Nussler NC, Settmacher U, Haase R, et al. Diagnosis and treatment of arterial steal syndromes in liver transplant recipients. Liver Transpl. 2003;9:596–602.CrossRefGoogle Scholar
  43. 43.
    Uflacker R, Selby JB, Chavin K, et al. Transcatheter splenic artery occlusion for treatment of splenic artery steal syndrome after orthotopic liver transplantation. Cardiovasc Intervent Radiol. 2002;25:300–6.CrossRefGoogle Scholar
  44. 44.
    Shimizu H, Takastuka K, Yoshida A, et al. Partial splenic embolization reverses insulin resistance in patients with liver cirrhosis. Intern Med. 2009;48:747–51.CrossRefGoogle Scholar
  45. 45.
    Masada T, Tanaka T, Sakaguchi H, et al. Coils versus gelatin particles with or without intraarterial antibiotics for partial splenic embolization: a comparative evaluation. J Vasc Interv Radiol. 2014;25:852–8.CrossRefGoogle Scholar
  46. 46.
    Yoshida H, Mamada Y, Taniai N, et al. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices. Hepatogastroenterology. 2009;56:1366–70.PubMedGoogle Scholar
  47. 47.
    Mozse MF, Spigos DG, Pollak R, et al. Partial splenic embolization, an alternative to splenectomy-results of a prospective, randomized study. Surgery. 1984;96:694–702.Google Scholar
  48. 48.
    Alwmark A, Bengmark S, Guulstrand P, et al. Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Surg. 1982;96:518–24.CrossRefGoogle Scholar
  49. 49.
    Sakai T, Shiraki K, Inoue H, et al. Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci. 2002;47:388–91.CrossRefGoogle Scholar
  50. 50.
    Ohmagari K, Toyonaga A, Tanikawa K. Effects of transcatheter splenic arterial embolization on portal hypertensive gastric mucosa. Am J Gastroenterol. 1993;88:1837–41.PubMedGoogle Scholar
  51. 51.
    Tajiri T, Onda M, Taniai N, et al. A comparison of combination endoscopic therapy and interventional radiology with esophageal trisection for the treatment of esophageal varices. Hepatogastroenterology. 2002;49:1552–4.PubMedGoogle Scholar
  52. 52.
    Mukaiya M, Hirata K, Yamashiro K, et al. Changes in portal hemodynamics and hepatic function after partial splenic embolization (PSE) and percutaneous transhepatic obliteration (PTO). Cancer Chemother Pharmacol. 1994;33:37–41.CrossRefGoogle Scholar
  53. 53.
    Barcena R, Moreno A, Foruny JR, et al. Improved graft function in liver-transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome? Clin Transpl. 2006;20:517–23.CrossRefGoogle Scholar
  54. 54.
    Jiao S, Chen H, Wang Y, et al. Splenectomy versus partial splenic embolization for massive splenomegaly secondary to hepatitis B-related liver cirrhosis: a case- control study. Gastroenterol Res Pract. 2016;2016:3471626.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Nobuhiko Taniai
    • 1
    Email author
  • Hiroshi Yoshida
    • 2
  • Eiigi Uchida
    • 2
  1. 1.Department of SurgeryNippon Medical School Musashi Kosugi HospitalTokyoJapan
  2. 2.Department of SurgeryNippon Medical School HospitalTokyoJapan

Personalised recommendations